Andrea Casiraghi
Via Luigi Mangiagalli 25
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.
Journal: Pharmaceutics
Published: May 17, 2022
Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux.
Journal: Communications biology
Published: May 03, 2022
Computational Design and Development of Benzodioxane-Benzamides as Potent Inhibitors of FtsZ by Exploring the Hydrophobic Subpocket.
Journal: Antibiotics (Basel, Switzerland)
Published: March 13, 2021
Staphylococcus aureus RnpA Inhibitors: Computational-Guided Design, Synthesis and Initial Biological Evaluation.
Journal: Antibiotics (Basel, Switzerland)
Published: March 12, 2021
Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram.
Journal: RSC medicinal chemistry
Published: March 06, 2021
Benzamide Derivatives Targeting the Cell Division Protein FtsZ: Modifications of the Linker and the Benzodioxane Scaffold and Their Effects on Antimicrobial Activity.
Journal: Antibiotics (Basel, Switzerland)
Published: March 03, 2020
Targeting Bacterial Cell Division: A Binding Site-Centered Approach to the Most Promising Inhibitors of the Essential Protein FtsZ.
Journal: Antibiotics (Basel, Switzerland)
Published: December 05, 2019
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
Journal: Neurobiology of disease
Published: November 07, 2019
Benzodioxane-Benzamides as Antibacterial Agents: Computational and SAR Studies to Evaluate the Influence of the 7-Substitution in FtsZ Interaction.
Journal: ChemMedChem
Published: September 19, 2019
Last Updated: 09/26/2026